Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EpiHeart logo — Enabling new cardiac treatments

EpiHeart

Enabling new cardiac treatments

Founded 2019 Finland Finland 5 employees Health Care, Manufacturing

General Information

Company Name EpiHeart
Founded Year 2019
Location Finland Finland +1
Employees 5
Industries Health Care, Manufacturing
Social

Get notified when EpiHeart moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EpiHeart

EpiHeart, founded in 2019 and based in Finland, is a promising player in the Health Care and Manufacturing sectors. Their focus is clear: enabling surgical administration of cutting-edge cellular and gene therapies aimed particularly at cardiac care.

Their innovation seeks to address significant challenges in the field of cardiac cellular therapy, specifically targeting ischemic cardiac scars and heart failure during CABG (Coronary Artery Bypass Grafting) or LVAD (Left Ventricular Assist Device) surgery. By doing so, EpiHeart is directly tackling the global burden of heart disease with potentially transformative solutions.

Despite not having reported any further investment rounds or specific investor involvement yet, EpiHeart's dedication to pioneering in cardiac treatment through novel medical devices positions it as an enticing prospect for potential investors looking to enter or expand within the healthcare innovation space.

Taxonomy: cardiac cellular therapy, medical device company, ischemic injury repair, CABG, LVAD surgery, heart failure treatment, cellular and gene therapies, ischemic cardiac scars, surgical administration, cardiac treatment innovation, novel therapies, cardiac surgery integration

Services & Products

Cardiac Micrograft Therapy
Development of advanced cardiac cell therapies
Clinical study collaboration

Target Customers

Cardiac surgery units Research institutions Medical distributors Healthcare professionals specializing in cardiac care

No funding data available for EpiHeart yet.

Get notified when EpiHeart raises funding

EpiHeart Alternatives & Competitors

View All Alternatives
EpiHeart vs
Metromed International Cardiac Centre Private Limited
Metromed International Cardiac Centre Private Limited

MICC is a tertiary refferal heart centre where every possible cardiac procedures are done under one...

248 employees
Health Care, Health and Wellness
EpiHeart vs
Voyage Biomedical
Voyage Biomedical United States

Developing a medical device to reduce brain damage from ischemic events

Pre Seed
1 employees
Health Care
EpiHeart vs
Rithim Biologics, Inc.
Rithim Biologics, Inc. United States

Toward a Normal Heart Rhythm

4 employees
Biotechnology
Compare EpiHeart vs Rithim Biologics, Inc.
View all alternatives

FAQ About EpiHeart

Enabling new cardiac treatments
EpiHeart was founded in 2019.
EpiHeart is headquartered in Finland.
EpiHeart operates in the following industries: Health Care, Manufacturing.
EpiHeart has approximately 5 employees.
EpiHeart offers: Cardiac Micrograft Therapy, Development of advanced cardiac cell therapies, Clinical study collaboration.
Top alternatives and competitors to EpiHeart include Metromed International Cardiac Centre Private Limited, Voyage Biomedical, Rithim Biologics, Inc., BEAT BioTherapeutics, CARDIVA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EpiHeart and Metromed International Cardiac Centre Private Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EpiHeart and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy